First patient dosed with ISP-001 shows reduced urinary GAG level, functional improvements surpassing enzyme replacement ...

In this GEN webinar, experts from Regeneron Pharmaceuticals will discuss two novel methods for characterizing AAV-based gene ...

Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of ...

Data from a new study suggests that in the early phase the damage to the brain starts slowly, before speeding up in the ...

Prenatal skin atlas and hair-growing skin organoids could inform on new approaches to enable scarless wound healing or ...

Scientists have created a global "superbug map," paving the way for scalable phage therapy to combat antibiotic-resistant infections in hospitals.

Identifying reliable operational parameters as early as possible in the development process can significantly streamline ...

As automation continues to expand in manufacturing, integrating various platforms and the data they generate becomes ...

The banning of a chemical in the EU has worldwide implications for biopharmaceutical manufacturing, but, thankfully, the ...

It is essential to increase the number of autonomous agents in bioprocess development for biopharma innovation.

The disruption of abnormal activity in the gut microbiome may increase our risk for neurological disease, research suggests.

When Sema4 Holdings rebranded as GeneDx Holdings (WGS) in January 2023, taking the name of a pioneer diagnostic test developer it acquired eight months earlier, the company was burning through ...